Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFΒ signaling Journal Article


Authors: Knauf, J. A.; Sartor, M. A.; Medvedovic, M.; Lundsmith, E.; Ryder, M.; Salzano, M.; Nikiforov, Y. E.; Giordano, T. J.; Ghossein, R. A.; Fagin, J. A.
Article Title: Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFΒ signaling
Abstract: Mice with thyroid-specific expression of oncogenic BRAF (Tg-Braf) develop papillary thyroid cancers (PTCs) that are locally invasive and have well-defined foci of poorly differentiated thyroid carcinoma (PDTC). To investigate the PTC-PDTC progression, we performed a microarray analysis using RNA from paired samples of PDTC and PTC collected from the same animals by laser capture microdissection. Analysis of eight paired samples revealed a profound deregulation of genes involved in cell adhesion and intracellular junctions, with changes consistent with an epithelial-mesenchymal transition (EMT). This was confirmed by immunohistochemistry, as vimentin expression was increased and E-cadherin lost in PDTC compared with adjacent PTC. Moreover, PDTC stained positively for phospho-Smad2, suggesting a role for transforming growth factor (TGF)Β in mediating this process. Accordingly, TGFΒ-induced EMT in primary cultures of thyroid cells from Tg-Braf mice, whereas wild-type thyroid cells retained their epithelial features. TGFΒ-induced Smad2 phosphorylation, transcriptional activity and induction of EMT required mitogen-activated protein kinase (MAPK) pathway activation in Tg-Braf thyrocytes. Hence, tumor initiation by oncogenic BRAF renders thyroid cells susceptible to TGFΒ-induced EMT, through a MAPK-dependent process. © 2011 Macmillan Publishers Limited All rights reserved.
Keywords: thyroid; braf; epithelialmesenchymal transition; tgfΒ
Journal Title: Oncogene
Volume: 30
Issue: 28
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 2011-07-14
Start Page: 3153
End Page: 3162
Language: English
DOI: 10.1038/onc.2011.44
PROVIDER: scopus
PMCID: PMC3136543
PUBMED: 21383698
DOI/URL:
Notes: --- - "Export Date: 17 August 2011" - "CODEN: ONCNE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James A Fagin
    181 Fagin
  2. Jeffrey A Knauf
    61 Knauf
  3. Mabel M Ryder
    18 Ryder
  4. Ronald A Ghossein
    490 Ghossein